Nordic NanoBio is an innovative biotechnology company based in Northern Sweden, emerging as a dynamic spin-off from Umeå University. Founded by leading experts with over 20 years of experience in the field of nanobiotechnology, the company is driven by a mission to advance precision medicine through cutting-edge technologies.
Nordic NanoBio is at the forefront of developing next-generation Omics platforms and advanced biotech solutions that simplify and accelerate biomarker discovery and drug development. By integrating nanotechnology with molecular biology, the company empowers researchers, clinicians, and pharmaceutical developers with highly sensitive, reliable, and scalable tools that enhance diagnostic precision and therapeutic innovation.
Nordic NanoBio is committed to translating complex biotechnological innovations into practical applications that support healthier lives. The company aspires to become a global leader in precision medicine, enabling breakthroughs that bring personalized healthcare within reach for all.
Our team offers accurate biomedical testing products and services to uncover valuable insights for personalized healthcare and informed decision-making.
We specialize in drug development, employing cutting-edge techniques to create groundbreaking pharmaceutical solutions that benefit society.
Our bioprocessing support services ensure efficient production processes for biochemical products, enhancing sustainability and commercial viability.

CEO

CSO

CMO

Nicolas Boulanger
Director of Advanced Fabrication

Alexej Schmidt
Technical Advisor of Immunology